Continuous IL-12 required for protection against leishmaniasis?

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1999

Schlagwörter:	Parasitic Infection Leishmaniasis Cellular Immune Response Protective Immunity Cellular Immunity

Anmerkung:	© Adis International Ltd 1999

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1169(1999), 1 vom: Jan., Seite 13-13
Übergeordnetes Werk:	volume:1169 ; year:1999 ; number:1 ; month:01 ; pages:13-13

Links:	Volltext

DOI / URN:	10.2165/00128413-199911690-00013

Katalog-ID:	SPR036269387

Internformat


LEADER	01000caa a22002652 4500
001	SPR036269387
003	DE-627
005	20230519190109.0
007	cr uuu---uuuuu
008	201007s1999 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-199911690-00013 \|2 doi
035			\|a (DE-627)SPR036269387
035			\|a (SPR)00128413-199911690-00013-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Continuous IL-12 required for protection against leishmaniasis?
264		1	\|c 1999
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1999
650		4	\|a Parasitic Infection \|7 (dpeaa)DE-He213
650		4	\|a Leishmaniasis \|7 (dpeaa)DE-He213
650		4	\|a Cellular Immune Response \|7 (dpeaa)DE-He213
650		4	\|a Protective Immunity \|7 (dpeaa)DE-He213
650		4	\|a Cellular Immunity \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1169(1999), 1 vom: Jan., Seite 13-13 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1169 \|g year:1999 \|g number:1 \|g month:01 \|g pages:13-13
856	4	0	\|u https://dx.doi.org/10.2165/00128413-199911690-00013 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1169 \|j 1999 \|e 1 \|c 01 \|h 13-13

Indexfelder

matchkey_str	article:22306056:1999----::otnosl2eurdopoetoaa
hierarchy_sort_str	1999
publishDate	1999
allfields	10.2165/00128413-199911690-00013 doi (DE-627)SPR036269387 (SPR)00128413-199911690-00013-e DE-627 ger DE-627 rakwb eng Continuous IL-12 required for protection against leishmaniasis? 1999 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1999 Parasitic Infection (dpeaa)DE-He213 Leishmaniasis (dpeaa)DE-He213 Cellular Immune Response (dpeaa)DE-He213 Protective Immunity (dpeaa)DE-He213 Cellular Immunity (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1169(1999), 1 vom: Jan., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1169 year:1999 number:1 month:01 pages:13-13 https://dx.doi.org/10.2165/00128413-199911690-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1169 1999 1 01 13-13
spelling	10.2165/00128413-199911690-00013 doi (DE-627)SPR036269387 (SPR)00128413-199911690-00013-e DE-627 ger DE-627 rakwb eng Continuous IL-12 required for protection against leishmaniasis? 1999 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1999 Parasitic Infection (dpeaa)DE-He213 Leishmaniasis (dpeaa)DE-He213 Cellular Immune Response (dpeaa)DE-He213 Protective Immunity (dpeaa)DE-He213 Cellular Immunity (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1169(1999), 1 vom: Jan., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1169 year:1999 number:1 month:01 pages:13-13 https://dx.doi.org/10.2165/00128413-199911690-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1169 1999 1 01 13-13
allfields_unstemmed	10.2165/00128413-199911690-00013 doi (DE-627)SPR036269387 (SPR)00128413-199911690-00013-e DE-627 ger DE-627 rakwb eng Continuous IL-12 required for protection against leishmaniasis? 1999 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1999 Parasitic Infection (dpeaa)DE-He213 Leishmaniasis (dpeaa)DE-He213 Cellular Immune Response (dpeaa)DE-He213 Protective Immunity (dpeaa)DE-He213 Cellular Immunity (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1169(1999), 1 vom: Jan., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1169 year:1999 number:1 month:01 pages:13-13 https://dx.doi.org/10.2165/00128413-199911690-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1169 1999 1 01 13-13
allfieldsGer	10.2165/00128413-199911690-00013 doi (DE-627)SPR036269387 (SPR)00128413-199911690-00013-e DE-627 ger DE-627 rakwb eng Continuous IL-12 required for protection against leishmaniasis? 1999 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1999 Parasitic Infection (dpeaa)DE-He213 Leishmaniasis (dpeaa)DE-He213 Cellular Immune Response (dpeaa)DE-He213 Protective Immunity (dpeaa)DE-He213 Cellular Immunity (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1169(1999), 1 vom: Jan., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1169 year:1999 number:1 month:01 pages:13-13 https://dx.doi.org/10.2165/00128413-199911690-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1169 1999 1 01 13-13
allfieldsSound	10.2165/00128413-199911690-00013 doi (DE-627)SPR036269387 (SPR)00128413-199911690-00013-e DE-627 ger DE-627 rakwb eng Continuous IL-12 required for protection against leishmaniasis? 1999 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1999 Parasitic Infection (dpeaa)DE-He213 Leishmaniasis (dpeaa)DE-He213 Cellular Immune Response (dpeaa)DE-He213 Protective Immunity (dpeaa)DE-He213 Cellular Immunity (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1169(1999), 1 vom: Jan., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1169 year:1999 number:1 month:01 pages:13-13 https://dx.doi.org/10.2165/00128413-199911690-00013 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1169 1999 1 01 13-13
language	English
source	Enthalten in Inpharma weekly 1169(1999), 1 vom: Jan., Seite 13-13 volume:1169 year:1999 number:1 month:01 pages:13-13
sourceStr	Enthalten in Inpharma weekly 1169(1999), 1 vom: Jan., Seite 13-13 volume:1169 year:1999 number:1 month:01 pages:13-13
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Parasitic Infection Leishmaniasis Cellular Immune Response Protective Immunity Cellular Immunity
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1999-01-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036269387
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036269387</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519190109.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1999 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199911690-00013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036269387</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199911690-00013-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Continuous IL-12 required for protection against leishmaniasis?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1999</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1999</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parasitic Infection</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leishmaniasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cellular Immune Response</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protective Immunity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cellular Immunity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1169(1999), 1 vom: Jan., Seite 13-13</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1169</subfield><subfield code="g">year:1999</subfield><subfield code="g">number:1</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:13-13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199911690-00013</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1169</subfield><subfield code="j">1999</subfield><subfield code="e">1</subfield><subfield code="c">01</subfield><subfield code="h">13-13</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Continuous IL-12 required for protection against leishmaniasis? Parasitic Infection (dpeaa)DE-He213 Leishmaniasis (dpeaa)DE-He213 Cellular Immune Response (dpeaa)DE-He213 Protective Immunity (dpeaa)DE-He213 Cellular Immunity (dpeaa)DE-He213
topic	misc Parasitic Infection misc Leishmaniasis misc Cellular Immune Response misc Protective Immunity misc Cellular Immunity
spellingShingle	misc Parasitic Infection misc Leishmaniasis misc Cellular Immune Response misc Protective Immunity misc Cellular Immunity Continuous IL-12 required for protection against leishmaniasis?
topic_unstemmed	misc Parasitic Infection misc Leishmaniasis misc Cellular Immune Response misc Protective Immunity misc Cellular Immunity
topic_browse	misc Parasitic Infection misc Leishmaniasis misc Cellular Immune Response misc Protective Immunity misc Cellular Immunity
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Continuous IL-12 required for protection against leishmaniasis?
ctrlnum	(DE-627)SPR036269387 (SPR)00128413-199911690-00013-e
title_full	Continuous IL-12 required for protection against leishmaniasis?
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1999
contenttype_str_mv	txt
container_start_page	13
container_volume	1169
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-199911690-00013
title_sort	continuous il-12 required for protection against leishmaniasis?
title_auth	Continuous IL-12 required for protection against leishmaniasis?
abstract	© Adis International Ltd 1999
abstractGer	© Adis International Ltd 1999
abstract_unstemmed	© Adis International Ltd 1999
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Continuous IL-12 required for protection against leishmaniasis?
url	https://dx.doi.org/10.2165/00128413-199911690-00013
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-199911690-00013
up_date	2024-07-03T16:54:05.915Z
_version_	1803577611695161344
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036269387</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519190109.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1999 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199911690-00013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036269387</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199911690-00013-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Continuous IL-12 required for protection against leishmaniasis?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1999</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1999</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parasitic Infection</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leishmaniasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cellular Immune Response</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protective Immunity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cellular Immunity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1169(1999), 1 vom: Jan., Seite 13-13</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1169</subfield><subfield code="g">year:1999</subfield><subfield code="g">number:1</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:13-13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199911690-00013</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1169</subfield><subfield code="j">1999</subfield><subfield code="e">1</subfield><subfield code="c">01</subfield><subfield code="h">13-13</subfield></datafield></record></collection>
score	7.4001503

Nicht das Richtige dabei?

Schreiben Sie uns!

Continuous IL-12 required for protection against leishmaniasis?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?